Latest Insider Transactions at Edgewise Therapeutics, Inc. (EWTX)
This section provides a real-time view of insider transactions for Edgewise Therapeutics, Inc. (EWTX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Edgewise Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Edgewise Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 03
2022
|
John R Moore General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
9,232
+32.43%
|
$9,232
$1.32 P/Share
|
|
Jul 06
2022
|
John R Moore General Counsel |
SELL
Open market or private sale
|
Direct |
1,046
-25.85%
|
$8,368
$8.54 P/Share
|
|
Jul 06
2022
|
John R Moore General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
1,046
+20.54%
|
$1,046
$1.93 P/Share
|
|
Jul 05
2022
|
John R Moore General Counsel |
SELL
Open market or private sale
|
Direct |
8,186
-73.18%
|
$65,488
$8.35 P/Share
|
|
Jul 05
2022
|
John R Moore General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
8,186
+32.11%
|
$8,186
$1.32 P/Share
|
|
Jun 21
2022
|
John R Moore General Counsel |
SELL
Open market or private sale
|
Direct |
31,078
-91.2%
|
$217,546
$7.29 P/Share
|
|
Jun 21
2022
|
John R Moore General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
31,078
+39.51%
|
$31,078
$1.32 P/Share
|
|
Jun 17
2022
|
John R Moore General Counsel |
SELL
Open market or private sale
|
Direct |
22,127
-88.06%
|
$132,762
$6.62 P/Share
|
|
Jun 17
2022
|
John R Moore General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
22,127
+46.83%
|
$22,127
$1.93 P/Share
|
|
Jun 16
2022
|
John R Moore General Counsel |
SELL
Open market or private sale
|
Direct |
14,722
-83.07%
|
$88,332
$6.17 P/Share
|
|
Jun 16
2022
|
John R Moore General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
14,722
+45.38%
|
$14,722
$1.93 P/Share
|
|
Jun 15
2022
|
John R Moore General Counsel |
SELL
Open market or private sale
|
Direct |
18,660
-44.23%
|
$111,960
$6.11 P/Share
|
|
Jun 15
2022
|
John R Moore General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
18,660
+24.4%
|
$18,660
$1.32 P/Share
|
|
Jun 14
2022
|
John R Moore General Counsel |
SELL
Open market or private sale
|
Direct |
3,628
-54.74%
|
$21,768
$6.02 P/Share
|
|
Jun 14
2022
|
John R Moore General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
3,628
+35.37%
|
$0
$0.71 P/Share
|
|
Jun 13
2022
|
John R Moore General Counsel |
SELL
Open market or private sale
|
Direct |
4,093
-57.7%
|
$24,558
$6.01 P/Share
|
|
Jun 13
2022
|
John R Moore General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
4,093
+36.59%
|
$0
$0.71 P/Share
|
|
Jun 10
2022
|
John R Moore General Counsel |
SELL
Open market or private sale
|
Direct |
7,125
-70.37%
|
$42,750
$6.05 P/Share
|
|
Jun 10
2022
|
John R Moore General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
7,125
+41.3%
|
$0
$0.71 P/Share
|
|
Jun 09
2022
|
John R Moore General Counsel |
SELL
Open market or private sale
|
Direct |
7,615
-71.74%
|
$45,690
$6.49 P/Share
|
|
Jun 09
2022
|
John R Moore General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
7,615
+41.77%
|
$0
$0.71 P/Share
|
|
Jun 08
2022
|
John R Moore General Counsel |
SELL
Open market or private sale
|
Direct |
12,566
-80.73%
|
$75,396
$6.63 P/Share
|
|
Jun 08
2022
|
John R Moore General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
12,566
+44.67%
|
$0
$0.71 P/Share
|
|
Jun 07
2022
|
John R Moore General Counsel |
SELL
Open market or private sale
|
Direct |
18,123
-54.8%
|
$108,738
$6.61 P/Share
|
|
Jun 07
2022
|
John R Moore General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
18,123
+32.83%
|
$18,123
$1.32 P/Share
|
|
Jun 06
2022
|
John R Moore General Counsel |
SELL
Open market or private sale
|
Direct |
13,934
-82.28%
|
$83,604
$6.03 P/Share
|
|
Jun 06
2022
|
John R Moore General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
13,934
+45.14%
|
$13,934
$1.93 P/Share
|
|
Jun 03
2022
|
John R Moore General Counsel |
SELL
Open market or private sale
|
Direct |
15,230
-83.54%
|
$91,380
$6.05 P/Share
|
|
Jun 03
2022
|
John R Moore General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
15,230
+45.52%
|
$15,230
$1.93 P/Share
|
|
May 23
2022
|
R Michael Carruthers Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,000
+42.86%
|
$0
$0.71 P/Share
|
|
May 18
2022
|
Peter A. Thompson |
BUY
Open market or private purchase
|
Indirect |
138,000
+1.01%
|
$966,000
$7.21 P/Share
|
|
May 18
2022
|
Orbimed Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
138,000
+1.01%
|
$966,000
$7.21 P/Share
|
|
May 16
2022
|
John R Moore General Counsel |
SELL
Open market or private sale
|
Direct |
10,800
-78.26%
|
$75,600
$7.42 P/Share
|
|
Feb 25
2022
|
Jonathan D Root |
SELL
Other acquisition or disposition
|
Indirect |
3,473,543
-100.0%
|
-
|
|
Jan 21
2022
|
John R Moore General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
5,400
+30.4%
|
$0
$0.71 P/Share
|
|
Dec 28
2021
|
John R Moore General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
5,400
+43.68%
|
$0
$0.71 P/Share
|
|
Nov 30
2021
|
Alan J Russell Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
172,585
+31.33%
|
$0
$0.32 P/Share
|
|
Nov 15
2021
|
Alan J Russell Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
479
-96.03%
|
$9,101
$19.34 P/Share
|
|
Nov 12
2021
|
Alan J Russell Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
8,562
-94.7%
|
$162,678
$19.51 P/Share
|
|
Nov 11
2021
|
Alan J Russell Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
19,276
-42.0%
|
$385,520
$20.13 P/Share
|
|
Nov 10
2021
|
Alan J Russell Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
12,326
-15.45%
|
$234,194
$19.96 P/Share
|
|
Nov 09
2021
|
Alan J Russell Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
29,576
-23.92%
|
$591,520
$20.12 P/Share
|
|
Nov 08
2021
|
Alan J Russell Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
9,017
-11.38%
|
$180,340
$20.16 P/Share
|
|
Nov 05
2021
|
Alan J Russell Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
13,042
-7.07%
|
$260,840
$20.16 P/Share
|
|
Nov 04
2021
|
Alan J Russell Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
7,392
-7.42%
|
$140,448
$19.76 P/Share
|
|
Nov 03
2021
|
Alan J Russell Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
26,184
-7.23%
|
$471,312
$18.75 P/Share
|
|
Nov 02
2021
|
Alan J Russell Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
17,519
-12.22%
|
$297,823
$17.43 P/Share
|
|
Nov 01
2021
|
Alan J Russell Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
469
-0.33%
|
$8,442
$18.02 P/Share
|
|
Oct 15
2021
|
Alan J Russell Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,433
-0.49%
|
$25,794
$18.07 P/Share
|
|
Oct 14
2021
|
Alan J Russell Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
5,749
-3.81%
|
$103,482
$18.18 P/Share
|